Individuals with hypertension and diabetes mellitus are at high risk of cerebrovascular and cardiovascular morbidity and mortality. Recent advances in the multifactorial pathophysiology of atherogenesis provide important information about the complex interrelations between traditional risk factors, inflammation and oxidative stress in mediating all stages of atherosclerosis. The objective of the study was to determine if some inflammatory and oxidative stress markers in patients with arterial hypertension and diabetes mellitus differ from those in healthy age-matched controls. Our results revealed a significant difference in blood pro/antioxidant activities in hypertensive diabetics and the controls. The investigation of inflammatory and oxidative stress markers along with traditional risk factors proves useful in complex assessment of vascular risk and primary prophylaxis of cerebrovascular and cardiovascular events.
If the inline PDF is not rendering correctly, you can download the PDF file here.
1. Libby P Ridker P Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105(9): 1135-43.
2. Lind L. Circulating markers of inflammation and atherosclerosis. Atherosclerosis. 2003; 169(2): 203-14.
3. Danesh J Whincup P Walker M Lennon L Thomson A Appleby P et al. Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BM J. 2000;321 (7255): 199-204.
4. Castoldi G Galimbertim S Riva C Papagna R Querci F Casati M et al. Association between serum values of C-reactive protein and cytokine production in whole blood of patients with type 2 diabetes. Clin Sci (Lond). 2007; 113(2): 103-8.
5. Elkind M. Inflammatory mechanisms of stroke. Stroke. 2010; 41 (10 Suppl):S3-S8.
6. Libby P Ridker P. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med. 2004; 116(6 Suppl 1):9S-16S.
7. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med. 1999;340(2): 115-26.
8. Di Napoli M Elkind M Godoy D Singh P Papa F Popa-Wagner A. Role of C-reactive protein in cerebrovascular disease: a critical review. Expert Rev Cardiovasc Ther. 2011 ;9( 12): 1565-84.
9. Pasupathi P Farook J Chinnaswamy P. Oxidant-antioxidant status high sensitive C-reactive protein and homocysteine levels in type 2 diabetic patients with and without microalbuminuria. Int J Biol Med Res. 2010; 1 (3) :04-8.
10. Likidlilid A Patchanans N Peerapatdit T. Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients. J Med Assoc Thai. 2010;93(6):682-93.
11. Lindsberg P Grau A. Inflammation and infections as risk factors for ischemic stroke. Stroke. 2003;34(10):2518-32.
12. Saito M Ishimittsu T Minami J Ono H Ohrui M Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional risk factors. Atherosclerosis. 2003; 167( 1 ):73-9.
13. Anand A Manikandan R Begum T Kumar K Akilandeswari G Jerline M et al. Hypertension diabetes metabolic syndrome inflammation and the risk of stroke. Int J Biol Med Res. 2011 ;2( 1 ):429-32.
14. Savoia C Schiffrin E. Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions. Clin Sci (Lond). 2007; 112(7):375-84.
15. Di Napoli M Papa F. Inflammation hemostatic factors and antithrombotic agents in relation to long-term risk of new cardiovascular events in first-ever ischemic stroke patients. Stroke. 2002; 33:1763-71.
16. Ridker PM Silvertown JD. Inflammation C-reactive protein and atherothrombosis. J Periodontol. 2008;79(8 Suppl): 1544-51.
17. Biswas UK Kumar A. Study on lipid profile oxidation stress and carbonic anhydrase activity in patients with essential hypertension. J Clin Diag Res. 2010;4:3414-20.
18. Kusano C Ferrari B. Total antioxidant capacity: a biomarker in biomedical and nutritional studies. J Cell Mol Biol. 2008;7(1): 1-15.
19. Mahboob M Rahman M Grover P. Serum lipid peroxidation and antioxidant enzyme levels in male and female diabetic patients. Singapore Med J. 2005;46(7):322-4.